
The decision comes as the government comes up with a new draft policy for the treatment of rare diseases, more than a year after it withdrew the earlier policy that promised an initial corpus fund of Rs 100 crore for the treatment of patients with rare genetic diseases.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2tZVjiA
via
IFTTT
0 comments:
Post a Comment